Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic testing systems and kits and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, Polymerase Chain Reaction (PCR) master mixes and bioresearch reagents. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media; and Life Science, which develops, manufactures, sells and distributes bulk antigens, antibodies, immunoassay blocking reagents, PCR master mixes, isothermal reagents, enzymes, nucleotides and bioresearch reagents. When considering the Meridian Bioscience Inc. stock dividend history, we have taken known splits into account, such that the VIVO dividend history is presented on a split-adjusted ("apples to apples") basis. Meridian Bioscience Inc. dividend history is presented both in graphical/chart form, and as a VIVO dividend history data table along the right-hand column.
|
VIVO Stock Dividend HistoryThe VIVO dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable VIVO historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the VIVO dividend history record. Also see the VIVO stock dividend history data table along the right-hand column below. |
|
VIVO Next Dividend Date » (Projection based upon history) VIVO Dividend Growth Rate » Quotes delayed 20 minutes |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: VIVO Forecast Based on data provided by Zacks Investment Research via Quandl.com |
Projection: VIVO Next Dividend Date Chart: VIVO Chart - 5Yr Dividend Yield |